The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer

por Orlowski, Robert Z, Dees, E Claire
Publicado 2003

The warfarin–cranberry juice interaction revisited: A systematic in vitro–in vivo evaluation

por Ngo, Ngoc, Brantley, Scott J, Carrizosa, Daniel R, Kashuba, Angela DM, Dees, E Claire, Kroll, David J, Oberlies, Nicholas H, Paine, Mary F
Publicado 2010

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

por Soliman, Hatem H., Jackson, Erica, Neuger, Tony, Dees, E. Claire, Harvey, R. Donald, Han, Hyo, Ismail-Khan, Roohi, Minton, Susan, Vahanian, Nicholas N., Link, Charles, Sullivan, Daniel M., Antonia, Scott
Publicado 2014

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

por Locatelli, Marzia A., Aftimos, Philippe, Dees, E. Claire, LoRusso, Patricia M., Pegram, Mark D., Awada, Ahmad, Huang, Bo, Cesari, Rossano, Jiang, Yuqiu, Shaik, M. Naveed, Kern, Kenneth A., Curigliano, Giuseppe
Publicado 2016

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience

por McKee, Megan J., Keith, Kevin, Deal, Allison M., Garrett, Amy L., Wheless, Amy A., Green, Rebecca L., Benbow, Julie M., Dees, E. Claire, Carey, Lisa A., Ewend, Matthew G., Anders, Carey K., Zagar, Timothy M.
Publicado 2016

Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16(INK4a)

por Shachar, Shlomit S, Deal, Allison M, Reeder-Hayes, Katherine E, Nyrop, Kirsten A, Mitin, Natalia, Anders, Carey K, Carey, Lisa A, Dees, E Claire, Jolly, Trevor A, Kimmick, Gretchen G, Karuturi, Meghan S, Reinbolt, Raquel E, Speca, JoEllen C, Muss, Hyman B
Publicado 2020

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

por Tolaney, Sara M., Beeram, Muralidhar, Beck, J. Thaddeus, Conlin, Alison, Dees, E. Claire, Puhalla, Shannon L., Rexer, Brent N., Burris, Howard A., Jhaveri, Komal, Helsten, Teresa, Becerra, Carlos, Kalinsky, Kevin, Moore, Kathleen N., Manuel, Allison M., Lithio, Andrew, Price, Gregory L., Chapman, Sonya C., Litchfield, Lacey M., Goetz, Matthew P.
Publicado 2022

A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and...

por Nakamura, Zev M., Deal, Allison M., Park, Eliza M., Stanton, Kate E., Lopez, Yesy E., Quillen, Laura J., O’Hare Kelly, Erin, Heiling, Hillary M., Nyrop, Kirsten A., Ray, Emily M., Dees, E. Claire, Reeder‐Hayes, Katherine E., Jolly, Trevor A., Carey, Lisa A., Abdou, Yara, Olajide, Oludamilola A., Rauch, Julia K., Joseph, Ranjit, Copeland, Anureet, McNamara, Megan A., Ahles, Tim A., Muss, Hyman B.
Publicado 2023

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

por Anders, Carey K, Woodcock, Mark G, Van Swearingen, Amanda E D, Moore, Dominic T, Sambade, Maria J, Laurie, Sonia, Robeson, Alexander, Kolupaev, Oleg, Cuaboy, Luz A, Garrett, Amy L, McKinnon, Karen, Cowens, Kristen, Bortone, Dante, Calhoun, Benjamin C, Wilkinson, Alec D, Carey, Lisa, Jolly, Trevor, Muss, Hyman, Reeder-Hayes, Katherine, Kaltman, Rebecca, Jankowitz, Rachel, Gudena, Vinay, Olajide, Oludamilola, Perou, Charles, Dees, E Claire, Vincent, Benjamin G, Serody, Jonathan S
Publicado 2022

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

por Ademuyiwa, Foluso O., Gao, Feng, Street, Cherease R., Chen, Ina, Northfelt, Donald W., Wesolowski, Robert, Arora, Mili, Brufsky, Adam, Dees, E. Claire, Santa-Maria, Cesar A., Connolly, Roisin M., Force, Jeremy, Moreno-Aspitia, Alvaro, Herndon, John M., Carmody, Madelyn, Davies, Sherri R., Larson, Sarah, Pfaff, Kathleen L., Jones, Stephanie M., Weirather, Jason L., Giobbie-Hurder, Anita, Rodig, Scott J., Liu, Zheng, Hagemann, Ian S., Sharon, Elad, Gillanders, William E.
Publicado 2022

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

por Tomlins, Scott A., Khazanov, Nickolay A., Bulen, Benjamin J., Hovelson, Daniel H., Shreve, Melissa J., Lamb, Laura E., Matrana, Marc R., Burkard, Mark E., Yang, Eddy Shih-Hsin, Edenfield, William Jeffery, Dees, E. Claire, Onitilo, Adedayo A., Thompson, Michael, Buchschacher, Gary L., Miller, Alan M., Menter, Alexander, Parsons, Benjamin, Wassenaar, Timothy, Hwang, Leon C., Suga, J. Marie, Siegel, Robert, Irvin, William, Nair, Suresh, Slim, Jennifer N., Misleh, Jamal, Khatri, Jamil, Masters, Gregory, Thomas, Sachdev, Safa, Malek, Anderson, Daniel M., Kwiatkowski, Kat, Mitchell, Khalis, Hu-Seliger, Tina, Drewery, Stephanie, Fischer, Andrew, Plouffe, Komal, Czuprenski, Eric, Hipp, Jennifer, Reeder, Travis, Vakil, Hana, Johnson, D. Bryan, Rhodes, Daniel R.
Publicado 2023